| Year |
Citation |
Score |
| 2022 |
Schlesinger M, McDonald C, Ahuja A, Alvarez Canete CA, Nuñez Del Prado Z, Naipauer J, Lampidis T, Mesri EA. Glucose and mannose analogs inhibit KSHV replication by blocking N-glycosylation and inducing the unfolded protein response. Journal of Medical Virology. e28314. PMID 36380418 DOI: 10.1002/jmv.28314 |
0.363 |
|
| 2021 |
Mesri EA, Lampidis TJ. 2-Deoxy-D-glucose Exploits Increased Glucose Metabolism in Cancer and Viral- infected cells: Relevance to its use in INDIA Against SARS-CoV-2. Iubmb Life. PMID 34418270 DOI: 10.1002/iub.2546 |
0.393 |
|
| 2019 |
Nguyen DJ, Theodoropoulos G, Li YY, Wu C, Sha W, Feun LG, Lampidis TJ, Savaraj N, Wangpaichitr M. Targeting the kynurenine pathway for the treatment of cisplatin resistant lung cancer. Molecular Cancer Research : McR. PMID 31628200 DOI: 10.1158/1541-7786.Mcr-19-0239 |
0.707 |
|
| 2016 |
Liu H, Kurtoglu M, León-Annicchiarico CL, Munoz-Pinedo C, Barredo J, Leclerc G, Merchan J, Liu X, Lampidis TJ. Combining 2-deoxy-D-glucose with fenofibrate leads to tumor cell death mediated by simultaneous induction of energy and ER stress. Oncotarget. PMID 27183907 DOI: 10.18632/Oncotarget.9263 |
0.746 |
|
| 2015 |
Kovacs K, Decatur C, Toro M, Pham DG, Liu H, Jing Y, Murray TG, Lampidis TJ, Merchan JR. 2-DEOXY-GLUCOSE DOWN REGULATES ENDOTHELIAL AKT AND ERK VIA INTERFERENCE WITH N-LINKED GLYCOSYLATION, INDUCTION OF ENDOPASMIC RETICULUM STRESS AND GSK-3Β ACTIVATION. Molecular Cancer Therapeutics. PMID 26637370 DOI: 10.1158/1535-7163.Mct-14-0315 |
0.52 |
|
| 2015 |
Leclerc GJ, DeSalvo J, Du J, Gao N, Leclerc GM, Lehrman MA, Lampidis TJ, Barredo JC. Mcl-1 downregulation leads to the heightened sensitivity exhibited by BCR-ABL positive ALL to induction of energy and ER-stress. Leukemia Research. PMID 26346348 DOI: 10.1016/J.Leukres.2015.08.007 |
0.404 |
|
| 2015 |
León-Annicchiarico CL, Ramírez-Peinado S, Domínguez-Villanueva D, Gonsberg A, Lampidis TJ, Muñoz-Pinedo C. ATF4 mediates necrosis induced by glucose deprivation and apoptosis induced by 2-deoxyglucose in the same cells. The Febs Journal. 282: 3647-58. PMID 26172539 DOI: 10.1111/febs.13369 |
0.435 |
|
| 2015 |
Kovacs K, Decatur C, Pham DG, Liu H, Jing Y, Murray TG, Lampidis TJ, Merchan JR. Abstract 1382: 2-Deoxy-glucose downregulates endothelial Akt and Erk via interference with N-linked glycosylation, induction of endoplasmic reticulum stress, and GSK-3β activation Cancer Research. 75: 1382-1382. DOI: 10.1158/1538-7445.Am2015-1382 |
0.508 |
|
| 2014 |
Xi H, Kurtoglu M, Lampidis TJ. The wonders of 2-deoxy-D-glucose. Iubmb Life. 66: 110-21. PMID 24578297 DOI: 10.1002/Iub.1251 |
0.732 |
|
| 2014 |
Sullivan EJ, Kurtoglu M, Brenneman R, Liu H, Lampidis TJ. Targeting cisplatin-resistant human tumor cells with metabolic inhibitors. Cancer Chemotherapy and Pharmacology. 73: 417-27. PMID 24352250 DOI: 10.1007/S00280-013-2366-8 |
0.753 |
|
| 2014 |
Philips KB, Kurtoglu M, Leung HJ, Liu H, Gao N, Lehrman MA, Murray TG, Lampidis TJ. Increased sensitivity to glucose starvation correlates with downregulation of glycogen phosphorylase isoform PYGB in tumor cell lines resistant to 2-deoxy-D-glucose. Cancer Chemotherapy and Pharmacology. 73: 349-61. PMID 24292700 DOI: 10.1007/S00280-013-2358-8 |
0.801 |
|
| 2014 |
Leclerc GJ, DeSalvo J, Leclerc GM, Lampidis TJ, Barredo JC. BCR-ABL+ Bp-ALL Exhibits Heightened Sensitivity to Simultaneous Induction of Energy and ER Stress Via Downregulation of Mcl-1 Expression Blood. 124: 916-916. DOI: 10.1182/Blood.V124.21.916.916 |
0.449 |
|
| 2013 |
Liu H, Kurtoglu M, Cao Y, Xi H, Kumar R, Axten JM, Lampidis TJ. Conversion of 2-deoxyglucose-induced growth inhibition to cell death in normoxic tumor cells. Cancer Chemotherapy and Pharmacology. 72: 251-62. PMID 23700291 DOI: 10.1007/S00280-013-2193-Y |
0.78 |
|
| 2013 |
Xi H, Barredo JC, Merchan JR, Lampidis TJ. Endoplasmic reticulum stress induced by 2-deoxyglucose but not glucose starvation activates AMPK through CaMKKβ leading to autophagy. Biochemical Pharmacology. 85: 1463-77. PMID 23500541 DOI: 10.1016/J.Bcp.2013.02.037 |
0.457 |
|
| 2013 |
Raez LE, Papadopoulos K, Ricart AD, Chiorean EG, Dipaola RS, Stein MN, Rocha Lima CM, Schlesselman JJ, Tolba K, Langmuir VK, Kroll S, Jung DT, Kurtoglu M, Rosenblatt J, Lampidis TJ. A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 71: 523-30. PMID 23228990 DOI: 10.1007/S00280-012-2045-1 |
0.72 |
|
| 2012 |
Leung HJ, Duran EM, Kurtoglu M, Andreansky S, Lampidis TJ, Mesri EA. Activation of the unfolded protein response by 2-deoxy-D-glucose inhibits Kaposi's sarcoma-associated herpesvirus replication and gene expression. Antimicrobial Agents and Chemotherapy. 56: 5794-803. PMID 22926574 DOI: 10.1128/Aac.01126-12 |
0.715 |
|
| 2012 |
Piña Y, Houston SK, Murray TG, Koru-Sengul T, Decatur C, Scott WK, Nathanson L, Clarke J, Lampidis TJ. Retinoblastoma treatment: impact of the glycolytic inhibitor 2-deoxy-d-glucose on molecular genomics expression in LH(BETA)T(AG) retinal tumors. Clinical Ophthalmology (Auckland, N.Z.). 6: 817-30. PMID 22701083 DOI: 10.2147/Opth.S29688 |
0.416 |
|
| 2012 |
DeSalvo J, Kuznetsov JN, Du J, Leclerc GM, Leclerc GJ, Lampidis TJ, Barredo JC. Inhibition of Akt potentiates 2-DG-induced apoptosis via downregulation of UPR in acute lymphoblastic leukemia. Molecular Cancer Research : McR. 10: 969-78. PMID 22692960 DOI: 10.1158/1541-7786.Mcr-12-0125 |
0.533 |
|
| 2012 |
Piña Y, Decatur C, Murray TG, Houston SK, Lopez-Cavalcante M, Hernandez E, Celdran M, Shah N, Feuer W, Lampidis T. Retinoblastoma treatment: Utilization of the glycolytic inhibitor, 2-deoxy-2-fluoro-d-glucose (2-FG), to target the chemoresistant hypoxic regions in LH BETAT AG retinal tumors Investigative Ophthalmology and Visual Science. 53: 996-1002. PMID 22266512 DOI: 10.1167/Iovs.11-8265 |
0.399 |
|
| 2012 |
Wangpaichitr M, Sullivan EJ, Theodoropoulos G, Wu C, You M, Feun LG, Lampidis TJ, Kuo MT, Savaraj N. The relationship of thioredoxin-1 and cisplatin resistance: its impact on ROS and oxidative metabolism in lung cancer cells. Molecular Cancer Therapeutics. 11: 604-15. PMID 22248473 DOI: 10.1158/1535-7163.Mct-11-0599 |
0.709 |
|
| 2012 |
Savaraj N, Xu R, Landy H, Lai S, Sternau L, Solomon J, Wu C, Lampidis T, Feun L. Comparison of topoisomerase I and II expression in primary brain tumor and lung cancer. Oncology Reports. 4: 857-61. PMID 21590157 DOI: 10.3892/Or.4.4.857 |
0.305 |
|
| 2012 |
Kuznetsov JN, DeSalvo J, Du J, Leclerc GM, Leclerc GJ, Lampidis TJ, Barredo JC. Abstract 4991: Akt and AMPK modulate UPR activity and determine ER stress-induced cell death in response to 2-DG in ALL Cancer Research. 72: 4991-4991. DOI: 10.1158/1538-7445.Am2012-4991 |
0.46 |
|
| 2012 |
Wangpaichitr M, Theodoropoulos G, Wu C, You M, Feun LG, Kuo MT, Lampidis TJ, Savaraj N. Abstract 1138: The emerging role of thioredoxin-1 on ROS and metabolic reprogramming in cisplatin resistant lung cancer Cancer Research. 72: 1138-1138. DOI: 10.1158/1538-7445.Am2012-1138 |
0.705 |
|
| 2011 |
Xi H, Kurtoglu M, Liu H, Wangpaichitr M, You M, Liu X, Savaraj N, Lampidis TJ. 2-Deoxy-D-glucose activates autophagy via endoplasmic reticulum stress rather than ATP depletion. Cancer Chemotherapy and Pharmacology. 67: 899-910. PMID 20593179 DOI: 10.1007/S00280-010-1391-0 |
0.814 |
|
| 2011 |
Piña Y, Decatur C, Murray TG, Houston SK, Gologorsky D, Cavalcante M, Cavalcante L, Hernandez E, Celdran M, Feuer W, Lampidis T. Advanced retinoblastoma treatment: Targeting hypoxia by inhibition of the mammalian target of rapamycin (mTOR) in LHBETATAG retinal tumors Clinical Ophthalmology. 5: 337-343. DOI: 10.2147/Opth.S16172 |
0.345 |
|
| 2011 |
Sullivan EJ, Kurtoglu M, Wangpaichitr M, Savaraj N, Lampidis T. Abstract 4087: Metabolic changes associated with acquired cisplatin resistance Cellular and Molecular Biology. 71: 4087-4087. DOI: 10.1158/1538-7445.Am2011-4087 |
0.76 |
|
| 2011 |
Philips KB, Kurtoglu M, Lampidis TJ. Abstract 4064: Overcoming resistance to 2-deoxy-glucose and glucose deprivation in tumor cells under normoxia by modulating the unfolded protein response Cellular and Molecular Biology. 71: 4064-4064. DOI: 10.1158/1538-7445.Am2011-4064 |
0.801 |
|
| 2011 |
Leung HJ, Duran M, Kurtoglu M, Lampidis TJ, Mesri EA. Abstract 2725: 2-Deoxyglucose inhibits KSHV replication under normoxic conditions Cancer Research. 71: 2725-2725. DOI: 10.1158/1538-7445.Am2011-2725 |
0.747 |
|
| 2010 |
Merchan JR, Kovács K, Railsback JW, Kurtoglu M, Jing Y, Piña Y, Gao N, Murray TG, Lehrman MA, Lampidis TJ. Antiangiogenic activity of 2-deoxy-D-glucose. Plos One. 5: e13699. PMID 21060881 DOI: 10.1371/Journal.Pone.0013699 |
0.774 |
|
| 2010 |
Piña Y, Houston SK, Murray TG, Boutrid H, Celdran M, Feuer W, Shi W, Hernandez E, Lampidis TJ. Focal, periocular delivery of 2-deoxy-d-glucose as adjuvant to chemotherapy for treatment of advanced retinoblastoma Investigative Ophthalmology and Visual Science. 51: 6149-6156. PMID 20702830 DOI: 10.1167/Iovs.09-5033 |
0.34 |
|
| 2010 |
Kurtoglu M, Philips K, Liu H, Boise LH, Lampidis TJ. High endoplasmic reticulum activity renders multiple myeloma cells hypersensitive to mitochondrial inhibitors. Cancer Chemotherapy and Pharmacology. 66: 129-40. PMID 19779717 DOI: 10.1007/S00280-009-1143-1 |
0.763 |
|
| 2010 |
Xi H, Kurtoglu M, Liu H, Wangpaichitr M, You M, Savaraj N, Lampidis TJ. Abstract 4840: 2-Deoxy-D-glucose induces autophagy through endoplasmic reticulum stress rather than by lowering ATP Cancer Research. 70: 4840-4840. DOI: 10.1158/1538-7445.Am10-4840 |
0.817 |
|
| 2009 |
Kurtoglu M, Lampidis TJ. From delocalized lipophilic cations to hypoxia: blocking tumor cell mitochondrial function leads to therapeutic gain with glycolytic inhibitors. Molecular Nutrition & Food Research. 53: 68-75. PMID 19072739 DOI: 10.1002/Mnfr.200700457 |
0.773 |
|
| 2008 |
Wangpaichitr M, Wu C, You M, Kuo MT, Feun L, Lampidis T, Savaraj N. Inhibition of mTOR restores cisplatin sensitivity through down-regulation of growth and anti-apoptotic proteins. European Journal of Pharmacology. 591: 124-7. PMID 18585380 DOI: 10.1016/J.Ejphar.2008.06.028 |
0.707 |
|
| 2008 |
Wangpaichitr M, Savaraj N, Maher J, Kurtoglu M, Lampidis TJ. Intrinsically lower AKT, mammalian target of rapamycin, and hypoxia-inducible factor activity correlates with increased sensitivity to 2-deoxy-D-glucose under hypoxia in lung cancer cell lines. Molecular Cancer Therapeutics. 7: 1506-13. PMID 18566221 DOI: 10.1158/1535-7163.Mct-07-2334 |
0.807 |
|
| 2008 |
Subbarayan PR, Wang PG, Lampidis TJ, Ardalan B, Braunschweiger P. Differential expression of Glut 1 mRNA and protein levels correlates with increased sensitivity to the glyco-conjugated nitric oxide donor (2-glu-SNAP) in different tumor cell types. Journal of Chemotherapy (Florence, Italy). 20: 106-11. PMID 18343752 DOI: 10.1179/joc.2008.20.1.106 |
0.365 |
|
| 2008 |
Boutrid H, Jockovich ME, Murray TG, Piña Y, Feuer WJ, Lampidis TJ, Cebulla CM. Targeting hypoxia, a novel treatment for advanced retinoblastoma. Investigative Ophthalmology & Visual Science. 49: 2799-805. PMID 18326690 DOI: 10.1167/Iovs.08-1751 |
0.389 |
|
| 2007 |
Kurtoglu M, Gao N, Shang J, Maher JC, Lehrman MA, Wangpaichitr M, Savaraj N, Lane AN, Lampidis TJ. Under normoxia, 2-deoxy-D-glucose elicits cell death in select tumor types not by inhibition of glycolysis but by interfering with N-linked glycosylation. Molecular Cancer Therapeutics. 6: 3049-58. PMID 18025288 DOI: 10.1158/1535-7163.Mct-07-0310 |
0.821 |
|
| 2007 |
Kurtoglu M, Maher JC, Lampidis TJ. Differential toxic mechanisms of 2-deoxy-D-glucose versus 2-fluorodeoxy-D-glucose in hypoxic and normoxic tumor cells. Antioxidants & Redox Signaling. 9: 1383-90. PMID 17627467 DOI: 10.1089/Ars.2007.1714 |
0.829 |
|
| 2007 |
Maher JC, Wangpaichitr M, Savaraj N, Kurtoglu M, Lampidis TJ. Hypoxia-inducible factor-1 confers resistance to the glycolytic inhibitor 2-deoxy-D-glucose. Molecular Cancer Therapeutics. 6: 732-41. PMID 17308069 DOI: 10.1158/1535-7163.Mct-06-0407 |
0.812 |
|
| 2006 |
Lampidis TJ, Kurtoglu M, Maher JC, Liu H, Krishan A, Sheft V, Szymanski S, Fokt I, Rudnicki WR, Ginalski K, Lesyng B, Priebe W. Efficacy of 2-halogen substituted D-glucose analogs in blocking glycolysis and killing "hypoxic tumor cells". Cancer Chemotherapy and Pharmacology. 58: 725-34. PMID 16555088 DOI: 10.1007/S00280-006-0207-8 |
0.821 |
|
| 2005 |
Savaraj N, Wu C, Landy H, Wangpaijit M, Wei Y, Kuo MT, Robles C, Furst AJ, Lampidis T, Feun L. Procollagen alpha 1 type 1: a potential aide in histopathological grading of glioma. Cancer Investigation. 23: 577-81. PMID 16305983 DOI: 10.1080/07357900500276915 |
0.32 |
|
| 2005 |
Wu C, Wangpaichitr M, Feun L, Kuo MT, Robles C, Lampidis T, Savaraj N. Overcoming cisplatin resistance by mTOR inhibitor in lung cancer. Molecular Cancer. 4: 25. PMID 16033649 DOI: 10.1186/1476-4598-4-25 |
0.686 |
|
| 2005 |
Maher JC, Savaraj N, Priebe W, Liu H, Lampidis TJ. Differential sensitivity to 2-deoxy-D-glucose between two pancreatic cell lines correlates with GLUT-1 expression. Pancreas. 30: e34-9. PMID 15714127 DOI: 10.1097/01.Mpa.0000153327.46945.26 |
0.816 |
|
| 2004 |
Maschek G, Savaraj N, Priebe W, Braunschweiger P, Hamilton K, Tidmarsh GF, De Young LR, Lampidis TJ. 2-deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo. Cancer Research. 64: 31-4. PMID 14729604 DOI: 10.1158/0008-5472.Can-03-3294 |
0.519 |
|
| 2004 |
Maher JC, Krishan A, Lampidis TJ. Greater cell cycle inhibition and cytotoxicity induced by 2-deoxy-D-glucose in tumor cells treated under hypoxic vs aerobic conditions. Cancer Chemotherapy and Pharmacology. 53: 116-22. PMID 14605866 DOI: 10.1007/S00280-003-0724-7 |
0.832 |
|
| 2003 |
Savaraj N, Wu C, Wangpaichitr M, Kuo MT, Lampidis T, Robles C, Furst AJ, Feun L. Overexpression of mutated MRP4 in cisplatin resistant small cell lung cancer cell line: collateral sensitivity to azidothymidine. International Journal of Oncology. 23: 173-9. PMID 12792791 |
0.662 |
|
| 2003 |
Hu YP, Haq B, Carraway KL, Savaraj N, Lampidis TJ. Multidrug resistance correlates with overexpression of Muc4 but inversely with P-glycoprotein and multidrug resistance related protein in transfected human melanoma cells. Biochemical Pharmacology. 65: 1419-25. PMID 12732353 DOI: 10.1016/S0006-2952(03)00086-8 |
0.452 |
|
| 2003 |
Savaraj N, Wu C, Wangpaichitr M, Kuo MT, Lampidis T, Robles C, Furst AJ, Feun L. Overexpression of mutated MRP4 in cisplatin resistant small cell lung cancer cell line: collateral sensitivity to azidothymidine. International Journal of Oncology. 23: 173-179. DOI: 10.3892/Ijo.23.1.173 |
0.688 |
|
| 2002 |
Liu H, Savaraj N, Priebe W, Lampidis TJ. Hypoxia increases tumor cell sensitivity to glycolytic inhibitors: a strategy for solid tumor therapy (Model C). Biochemical Pharmacology. 64: 1745-51. PMID 12445863 DOI: 10.1016/S0006-2952(02)01456-9 |
0.454 |
|
| 2001 |
Liu H, Hu YP, Savaraj N, Priebe W, Lampidis TJ. Hypersensitization of tumor cells to glycolytic inhibitors. Biochemistry. 40: 5542-7. PMID 11331019 DOI: 10.1021/Bi002426W |
0.511 |
|
| 2000 |
Hu YP, Moraes CT, Savaraj N, Priebe W, Lampidis TJ. ρ0 Tumor cells: A model for studying whether mitochondria are targets for rhodamine 123, doxorubicin, and other drugs Biochemical Pharmacology. 60: 1897-1905. PMID 11108806 DOI: 10.1016/S0006-2952(00)00513-X |
0.429 |
|
| 2000 |
Zou J, Landy H, Feun L, Xu R, Lampidis T, Wu CJ, Furst AJ, Savaraj N. Correlation of a unique 220-kDa protein with vitamin D sensitivity in glioma cells. Biochemical Pharmacology. 60: 1361-5. PMID 11008130 DOI: 10.1016/S0006-2952(00)00438-X |
0.419 |
|
| 1998 |
Teillaud JL, Gruel N, Moncuit J, Mishal Z, Fridman WH, Lampidis TJ, Tapiero H. Structurally different anthracyclines provoke different effects on cell cycle and tumor B cell differentiation. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 52: 282-90. PMID 9755828 DOI: 10.1016/S0753-3322(98)80014-0 |
0.394 |
|
| 1998 |
Brouty-Boyé D, Doucet C, Clay D, Le Bousse-Kerdiles MC, Lampidis TJ, Azzarone B. Phenotypic diversity in human fibroblasts from myelometaplasic and non-myelometaplasic hematopoietic tissues. International Journal of Cancer. Journal International Du Cancer. 76: 767-73. PMID 9610738 DOI: 10.1002/(Sici)1097-0215(19980529)76:5<767::Aid-Ijc24>3.0.Co;2-# |
0.308 |
|
| 1997 |
Savaraj N, Wu CJ, Xu R, Lampidis T, Lai S, Donnelly E, Solomon J, Feun LG. Multidrug-resistant gene expression in small-cell lung cancer. American Journal of Clinical Oncology. 20: 398-403. PMID 9256898 DOI: 10.1097/00000421-199708000-00016 |
0.385 |
|
| 1997 |
Lampidis TJ, Kolonias D, Podona T, Israel M, Safa AR, Lothstein L, Savaraj N, Tapiero H, Priebe W. Circumvention of P-GP MDR as a function of anthracycline lipophilicity and charge. Biochemistry. 36: 2679-85. PMID 9054575 DOI: 10.1021/Bi9614489 |
0.362 |
|
| 1995 |
Brouty-Boye D, Kolonias D, Lampidis TJ. Antiproliferative activity of taxol on human tumor and normal breast cells vs. effects on cardiac cells. International Journal of Cancer. 60: 571-5. PMID 7829273 DOI: 10.1002/Ijc.2910600424 |
0.399 |
|
| 1994 |
Savaraj N, Lampidis TJ, Zhao JY, Wu CJ, Teeter LD, Kuo MT. Two multidrug-resistant Friend leukemic cell lines selected with different drugs exhibit overproduction of different P-glycoproteins. Cancer Investigation. 12: 138-44. PMID 7907527 DOI: 10.3109/07357909409024869 |
0.389 |
|
| 1993 |
Dellinger M, Moreno G, Salet C, Tapiero H, Lampidis TJ. Cytotoxic and photodynamic effects of Photofrin on sensitive and multi-drug-resistant Friend leukaemia cells. International Journal of Radiation Biology. 62: 735-41. PMID 1362767 DOI: 10.1080/09553009214552691 |
0.425 |
|
| 1990 |
Lampidis TJ, Castello C, del Giglio A, Pressman BC, Viallet P, Trevorrow KW, Valet GK, Tapiero H, Savaraj N. Relevance of the chemical charge of rhodamine dyes to multiple drug resistance. Biochemical Pharmacology. 38: 4267-71. PMID 2597199 DOI: 10.1016/0006-2952(89)90525-X |
0.361 |
|
| 1989 |
Hasmann M, Valet GK, Tapiero H, Trevorrow K, Lampidis T. Membrane potential differences between adriamycin-sensitive and -resistant cells as measured by flow cytometry. Biochemical Pharmacology. 38: 305-12. PMID 2914014 DOI: 10.1016/0006-2952(89)90041-5 |
0.42 |
|
| 1988 |
Tapiero H, Boulé D, Trincal G, Fourcade A, Lampidis TJ. Potentiation of adriamycin accumulation and effectiveness in adriamycin-resistant cells by aclacinomycin A. Leukemia Research. 12: 411-8. PMID 3164087 DOI: 10.1016/0145-2126(88)90060-4 |
0.422 |
|
| 1987 |
Lampidis TJ, Krishan A, Planas L, Tapiero H. Reversal of intrinsic resistance to adriamycin in normal cells by verapamil. Cancer Drug Delivery. 3: 251-9. PMID 3567846 DOI: 10.1089/Cdd.1986.3.251 |
0.424 |
|
| 1985 |
Abou-Khalil S, Abou-Khalil WH, Planas L, Tapiero H, Lampidis TJ. Interaction of rhodamine 123 with mitochondria isolated from drug-sensitive and -resistant Friend leukemia cells. Biochemical and Biophysical Research Communications. 127: 1039-44. PMID 3985951 DOI: 10.1016/S0006-291X(85)80049-8 |
0.42 |
|
| 1984 |
Lampidis TJ, Salet C, Moreno G, Chen LB. Effects of the mitochondrial probe rhodamine 123 and related analogs on the function and viability of pulsating myocardial cells in culture. Agents and Actions. 14: 751-7. PMID 6475672 DOI: 10.1007/Bf01978920 |
0.361 |
|
| 1983 |
Bernal SD, Lampidis TJ, Summerhayes IC, Chen LB. Rhodamine-123 selectively reduces clonal growth of carcinoma cells in vitro. Science (New York, N.Y.). 218: 1117-9. PMID 7146897 DOI: 10.1126/Science.7146897 |
0.347 |
|
| 1983 |
Bernal SD, Lampidis TJ, McIsaac RM, Chen LB. Anticarcinoma activity in vivo of rhodamine 123, a mitochondrial-specific dye. Science (New York, N.Y.). 222: 169-72. PMID 6623064 DOI: 10.1126/Science.6623064 |
0.341 |
|
| 1982 |
Chen LB, Summerhayes IC, Johnson LV, Walsh ML, Bernal SD, Lampidis TJ. Probing mitochondria in living cells with rhodamine 123. Cold Spring Harbor Symposia On Quantitative Biology. 46: 141-55. PMID 6955079 DOI: 10.1101/Sqb.1982.046.01.018 |
0.348 |
|
| 1982 |
Summerhayes IC, Lampidis TJ, Bernal SD, Nadakavukaren JJ, Nadakavukaren KK, Shepherd EL, Chen LB. Unusual retention of rhodamine 123 by mitochondria in muscle and carcinoma cells. Proceedings of the National Academy of Sciences of the United States of America. 79: 5292-6. PMID 6752944 DOI: 10.1073/Pnas.79.17.5292 |
0.345 |
|
| 1982 |
Lampidis TJ, Bernal SD, Summerhayes IC, Chen LB. RHODAMINE-123 IS SELECTIVELY TOXIC AND PREFERENTIALLY RETAINED IN CARCINOMA CELLS IN VITRO Annals of the New York Academy of Sciences. 397: 299-302. DOI: 10.1111/J.1749-6632.1982.Tb43444.X |
0.35 |
|
| 1979 |
Lampidis TJ, Moreno G, Salet C, Vinzens F. Nuclear and mitochondrial effects of adriamycin in singly isolated pulsating myocardial cells. Journal of Molecular and Cellular Cardiology. 11: 415-22. PMID 439146 DOI: 10.1016/0022-2828(79)90427-9 |
0.339 |
|
| 1976 |
Lampidis TJ, Weichselbaum RR, Little JB. Letter: Gamma-irradiation of mammalian beating heart cells in vitro. Effects on cellular function. International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine. 28: 99-102. PMID 1081094 DOI: 10.1080/09553007514550801 |
0.306 |
|
| Show low-probability matches. |